BODI Bodisen

RNS Number:8908U
Bodisen Biotech Inc
16 April 2007


                             Bodisen Biotech, Inc.

               Preliminary Financial Results for Fiscal Year 2006


Shaanxi, China - April 16, 2007 - Bodisen Biotech, Inc. (the "Company") (OTC
Pink Sheets: BBCZ; London AIM:BODI; website: www.bodisen.com) today announced
its unaudited operating results for the fiscal year ended December 31, 2006.


The Company is pleased to announce that for the year ended December 31, 2006,
net revenue increased 41% to $43.6 million from $31.0 million for the year ended
December 31, 2005 and this is in line with the guidance provided in an
announcement released on January 8, 2007.   The gross profit margin on net
revenue for the year ended December 31, 2006 was 39% compared to gross profit on
net revenue of 37% for the year ended December 31, 2005.


Net income for the year ended December 31, 2006 was $14.1 million, or $0.79 per
share ($0.78 per share diluted) (excluding any extraordinary legal and other
expenses related to the Company's Amex deficiency issue and stockholder
lawsuits), compared to net income of $7.4 million, or $0.48 per share ($0.48 per
share diluted) for the year ended December 31, 2005.  This is ahead of the
guidance previously provided when the Company expected net income of $12.9
million.


Weighted average shares outstanding for 2006 were 17,966,090 (18,072,433
diluted), compared to 15,427,494 (15,589,336 diluted) for 2005.


The full audited accounts for the fiscal year ended December 31, 2006 are
expected to be available by the end of this month.


About Bodisen Biotech, Inc.


Bodisen Biotech Inc. is a leading manufacturer of liquid and organic compound
fertilizers, pesticides, insecticides and agricultural raw materials certified
by the Petroleum Chemical Industry Administrative office of China (Chemical
Petroleum Production Administrative Bureau), Shaanxi provincial government and
Chinese government. The Company is headquartered in Shaanxi province and is a
Delaware corporation. The Company's environmentally friendly "green" products
have been proven to improve soil and plant quality, and increase crop yields.


Safe Harbor Statement


This press release may contain forward-looking statements within the meaning of
the "safe harbor" provisions of the Private Securities Litigation Reform Act of
1995. These statements are based on the current expectations or beliefs of
Bodisen Biotech, Inc. management and are subject to a number of factors and
uncertainties, and the outcome of events may differ materially from those
described in the forward-looking statements, including but not limited to the
date on which the Company will file its Annual Report.


Enquiries:


Charles Stanley Securities

Richard Thompson / Philip Davies                        020 7149 6000



                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

MSCGUUWCCUPMUMQ

Bodisen Biotech (LSE:BODI)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024

Bodisen Biotech (LSE:BODI)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024